← FDA DRUG APPROVALS

FDA ANDA · ANDA203877

DOCETAXEL

Sponsor: TEVA PHARMS USA

APPLICATION
ANDA203877
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-16
LATEST ACTION
2020-07-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOCETAXELDiscontinued
DOCETAXEL 80MG/4ML (20MG/ML) · INJECTABLE · INJECTION
DOCETAXELDiscontinued
DOCETAXEL 20MG/ML (20MG/ML) · INJECTABLE · INJECTION

Approval history

2020-07-28Labeling · Supplement 3 · standardAP
2020-07-28Labeling · Supplement 1 · standardAP
2015-09-16UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →